on 19 Nov 2024
Last Applicant/ Owned by
GSK Medicines Research Centre
Stevenage
GB
SG12NY
Serial Number
98432066 filed on 04th Mar 2024
Registration Number
N/A
Correspondent Address
Elizabeth K. Rucki
Filing Basis
1. intent to use
Disclaimer
NO DATA
Vaccines; Anti-infectives; Pharmaceutical preparations for the prevention of infectious diseases; Pharmaceutical preparations for the treatment of damaged skin and tissue, pain, inflammation, obesity, and infectious diseases; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, hem Read More
Vaccines; Anti-infectives; Pharmaceutical preparations for the prevention of infectious diseases; Pharmaceutical preparations for the treatment of damaged skin and tissue, pain, inflammation, obesity, and infectious diseases; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, hematological, bacterial, respiratory, neurological, gastrointestinal, dermatological, psychiatric, and immune system related diseases and disorders
N/A
N/A
No 98432066
No Service/Collective Mark
No 84278544
Yes
No
No
Yes
No
No
No
No
Status Date | Action Taken |
---|---|
19th Nov 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
19th Nov 2024 | PUBLISHED FOR OPPOSITION |
13th Nov 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
11th Oct 2024 | PREVIOUS ALLOWANCE COUNT WITHDRAWN |
11th Oct 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
10th Oct 2024 | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED |
10th Oct 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
10th Oct 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
19th Sep 2024 | SUSPENSION LETTER WRITTEN |
19th Sep 2024 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |